» Articles » PMID: 11533168

Expression of Respiratory Syncytial Virus-induced Chemokine Gene Networks in Lower Airway Epithelial Cells Revealed by CDNA Microarrays

Overview
Journal J Virol
Date 2001 Sep 5
PMID 11533168
Citations 119
Authors
Affiliations
Soon will be listed here.
Abstract

The Paramyxovirus respiratory syncytial virus (RSV) is the primary etiologic agent of serious epidemic lower respiratory tract disease in infants, immunosuppressed patients, and the elderly. Lower tract infection with RSV is characterized by a pronounced peribronchial mononuclear infiltrate, with eosinophilic and basophilic degranulation. Because RSV replication is restricted to airway epithelial cells, where RSV replication induces potent expression of chemokines, the epithelium is postulated to be a primary initiator of pulmonary inflammation in RSV infection. The spectrum of RSV-induced chemokines expressed by alveolar epithelial cells has not been fully investigated. In this report, we profile the kinetics and patterns of chemokine expression in RSV-infected lower airway epithelial cells (A549 and SAE). In A549 cells, membrane-based cDNA macroarrays and high-density oligonucleotide probe-based microarrays identified inducible expression of CC (I-309, Exodus-1, TARC, RANTES, MCP-1, MDC, and MIP-1 alpha and -1 beta), CXC (GRO-alpha, -beta, and -gamma, ENA-78, interleukin-8 [IL-8], and I-TAC), and CX(3)C (Fractalkine) chemokines. Chemokines not previously known to be expressed by RSV-infected cells were independently confirmed by multiprobe RNase protection assay, Northern blotting, and reverse transcription-PCR. High-density microarrays performed on SAE cells confirmed a similar pattern of RSV-inducible expression of CC chemokines (Exodus-1, RANTES, and MIP-1 alpha and -1 beta), CXC chemokines (I-TAC, GRO-alpha, -beta, and -gamma, and IL-8), and Fractalkine. In contrast, TARC, MCP-1, and MDC were not induced, suggesting the existence of distinct genetic responses for different types of airway-derived epithelial cells. Hierarchical clustering by agglomerative nesting and principal-component analyses were performed on A549-expressed chemokines; these analyses indicated that RSV-inducible chemokines are ordered into three related expression groups. These data profile the temporal changes in expression by RSV-infected lower airway epithelial cells of chemokines, chemotactic proteins which may be responsible for the complex cellular infiltrate in virus-induced respiratory inflammation.

Citing Articles

Inhibiting retinoic acid signaling in dendritic cells suppresses respiratory syncytial virus infection through enhanced antiviral immunity.

Farazuddin M, Acker G, Zourob J, OKonek J, Wong P, Morris S iScience. 2024; 27(7):110103.

PMID: 39045100 PMC: 11263793. DOI: 10.1016/j.isci.2024.110103.


Nasopharyngeal and Peripheral Blood Type II Interferon Signature Evaluation in Infants during Respiratory Syncytial Virus Infection.

Savino F, Dini M, Clemente A, Calvi C, Pau A, Galliano I Medicina (Kaunas). 2024; 60(2).

PMID: 38399546 PMC: 10890591. DOI: 10.3390/medicina60020259.


Regulation of host gene expression by J paramyxovirus.

Wrobel E, Jackson J, Abraham M, He B PLoS One. 2023; 18(11):e0294173.

PMID: 37963152 PMC: 10645344. DOI: 10.1371/journal.pone.0294173.


RSV replication modifies the XBP1s binding complex on the IRF1 upstream enhancer to potentiate the mucosal anti-viral response.

Qiao D, Xu X, Zhang Y, Yang J, Brasier A Front Immunol. 2023; 14:1197356.

PMID: 37564646 PMC: 10411192. DOI: 10.3389/fimmu.2023.1197356.


Innate Immunity, Epithelial Plasticity, and Remodeling in Asthma.

Brasier A Adv Exp Med Biol. 2023; 1426:265-285.

PMID: 37464126 DOI: 10.1007/978-3-031-32259-4_13.


References
1.
Becker S, Quay J, Koren H, Haskill J . Constitutive and stimulated MCP-1, GRO alpha, beta, and gamma expression in human airway epithelium and bronchoalveolar macrophages. Am J Physiol. 1994; 266(3 Pt 1):L278-86. DOI: 10.1152/ajplung.1994.266.3.L278. View

2.
Murphy P . The molecular biology of leukocyte chemoattractant receptors. Annu Rev Immunol. 1994; 12:593-633. DOI: 10.1146/annurev.iy.12.040194.003113. View

3.
Glezen W, Taber L, Frank A, KASEL J . Risk of primary infection and reinfection with respiratory syncytial virus. Am J Dis Child. 1986; 140(6):543-6. DOI: 10.1001/archpedi.1986.02140200053026. View

4.
KISCH A, Johnson K . A plaque assay for respiratory syncytial virus. Proc Soc Exp Biol Med. 1963; 112:583-9. DOI: 10.3181/00379727-112-28111. View

5.
Arnold R, Humbert B, Werchau H, Gallati H, Konig W . Interleukin-8, interleukin-6, and soluble tumour necrosis factor receptor type I release from a human pulmonary epithelial cell line (A549) exposed to respiratory syncytial virus. Immunology. 1994; 82(1):126-33. PMC: 1414862. View